help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yki-Jarvinen, H.
Right arrow Articles by Rutanen, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yki-Jarvinen, H.
Right arrow Articles by Rutanen, E. M.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 3227-3232, Copyright © 1995 by Endocrine Society


ARTICLES

Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo

H Yki-Jarvinen, S Makimattila, T Utriainen and EM Rutanen
Department of Medicine, University of Helsinki, Finland.

Serum sex hormone-binding globulin (SHBG) and insulin-like growth factor-binding protein 1 (IGFBP-1) concentrations have been suggested to be useful markers of insulin sensitivity. As the production of both proteins is inhibited by insulin in the liver, we postulated that their concentrations reflect whole body insulin sensitivity only when the latter parallels changes in endogenous insulin secretion. To test this hypothesis, we determined SHBG and IGFBP-1 concentrations, whole body insulin sensitivity (euglycemic insulin clamp; serum free insulin, approximately 400 pmol/L), and serum insulin and C peptide concentrations in 13 type 1 diabetic patients lacking endogenous insulin secretion and 34 matched normal subjects. Whole body insulin sensitivity was 50% lower in the type 1 diabetic patients (20 +/- 3 mumol/kg.min) than that in the normal subjects (40 +/- 3 mumol/kg.min; P < 0.001). Despite this, serum SHBG (45 +/- 4 vs. 29 +/- 2nmol/L; P < 0.002) and IGFBP-1 (14 +/- 3 vs. 2 +/- 1 micrograms/L; P < 0.002) concentrations were increased in the type 1 diabetic patients. In the normal subjects, SHBG (r = -0.49; P < 0.01) and IGFBP-1 (r = -0.49; P < 0.01) were inversely correlated with serum C peptide and positively correlated with whole body insulin sensitivity (r = 0.54; P < 0.005 and r = 0.54; P < 0.005, respectively). In the type 1 diabetic patients, SHBG and IGFBP-1 concentrations were disproportionately increased when related to insulin sensitivity, but appropriate when related to estimated portal insulin concentrations. Serum T4, free testosterone, and estradiol concentrations were similar in both groups. We conclude that SHBG and IGFBP-1 reflect hepatic insulinization and can only be used as markers of insulin sensitivity in individuals with intact insulin secretion.


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
B. B Yeap, S A P. Chubb, Z. Hyde, K. Jamrozik, G. J Hankey, L. Flicker, and P. E Norman
Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study
Eur. J. Endocrinol., October 1, 2009; 161(4): 591 - 598.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F Bonnet, B Balkau, J M Malecot, P Picard, C Lange, F Fumeron, R Aubert, V Raverot, H Dechaud, J Tichet, et al.
Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: interactions with adiponectin levels
Eur. J. Endocrinol., July 1, 2009; 161(1): 81 - 85.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. Maric
Sex, diabetes and the kidney
Am J Physiol Renal Physiol, April 1, 2009; 296(4): F680 - F688.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Kotronen, M. Lewitt, K. Hall, K. Brismar, and H. Yki-Jarvinen
Insulin-Like Growth Factor Binding Protein 1 as a Novel Specific Marker of Hepatic Insulin Sensitivity
J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4867 - 4872.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
S A Paul Chubb, Z. Hyde, O. P Almeida, L. Flicker, P. E Norman, K. Jamrozik, G. J Hankey, and B. B Yeap
Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study
Eur. J. Endocrinol., June 1, 2008; 158(6): 785 - 792.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. K. Danielson, M. L. Drum, and R. B. Lipton
Sex Hormone-Binding Globulin and Testosterone in Individuals With Childhood Diabetes
Diabetes Care, June 1, 2008; 31(6): 1207 - 1213.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Codner and H. F. Escobar-Morreale
Hyperandrogenism and Polycystic Ovary Syndrome in Women with Type 1 Diabetes Mellitus
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1209 - 1216.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Codner, N. Soto, P. Lopez, L. Trejo, A. Avila, F. C. Eyzaguirre, G. Iniguez, and F. Cassorla
Diagnostic Criteria for Polycystic Ovary Syndrome and Ovarian Morphology in Women with Type 1 Diabetes Mellitus
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2250 - 2256.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. Tomar, S. Dhindsa, A. Chaudhuri, P. Mohanty, R. Garg, and P. Dandona
Contrasting Testosterone Concentrations in Type 1 and Type 2 Diabetes
Diabetes Care, May 1, 2006; 29(5): 1120 - 1122.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Kupelian, S. T. Page, A. B. Araujo, T. G. Travison, W. J. Bremner, and J. B. McKinlay
Low Sex Hormone-Binding Globulin, Total Testosterone, and Symptomatic Androgen Deficiency Are Associated with Development of the Metabolic Syndrome in Nonobese Men
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 843 - 850.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
S. Tenhola, P. Halonen, J. Jaaskelainen, and R. Voutilainen
Serum markers of GH and insulin action in 12-year-old children born small for gestational age
Eur. J. Endocrinol., March 1, 2005; 152(3): 335 - 340.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. O. Goodarzi, S. Erickson, S. C. Port, R. I. Jennrich, and S. G. Korenman
{beta}-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 310 - 315.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P.-H. Ducluzeau, P. Cousin, E. Malvoisin, H. Bornet, H. Vidal, M. Laville, and M. Pugeat
Glucose-to-Insulin Ratio Rather than Sex Hormone-Binding Globulin and Adiponectin Levels Is the Best Predictor of Insulin Resistance in Nonobese Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3626 - 3631.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. W.C.M. van Dam, J. M. Dekker, E. G.W.M. Lentjes, F. P.T.H.M. Romijn, Y. M. Smulders, W. J. Post, J. A. Romijn, and H. M. J. Krans
Steroids in Adult Men With Type 1 Diabetes: A tendency to hypogonadism
Diabetes Care, June 1, 2003; 26(6): 1812 - 1818.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Taponen, H. Martikainen, M.-R. Jarvelin, J. Laitinen, A. Pouta, A.-L. Hartikainen, U. Sovio, M. I. McCarthy, S. Franks, and A. Ruokonen
Hormonal Profile of Women with Self-Reported Symptoms of Oligomenorrhea and/or Hirsutism: Northern Finland Birth Cohort 1966 Study
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 141 - 147.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Mesotten, P. J. D. Delhanty, F. Vanderhoydonc, K. V. Hardman, F. Weekers, R. C. Baxter, and G. van den Berghe
Regulation of Insulin-Like Growth Factor Binding Protein-1 during Protracted Critical Illness
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5516 - 5523.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. R. Denburg, M. E. Silfen, A. M. Manibo, D. Chin, L. S. Levine, M. Ferin, D. J. McMahon, C. Go, and S. E. Oberfield
Insulin Sensitivity and the Insulin-Like Growth Factor System in Prepubertal Boys with Premature Adrenarche
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5604 - 5609.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Battaglia, G. Regnani, F. Mancini, L. Iughetti, S. Bernasconi, A. Volpe, C. Flamigni, and S. Venturoli
Isolated Premature Pubarche: Ultrasonographic and Color Doppler Analysis--A Longitudinal Study
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3148 - 3154.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
B. Roldan, H. F. Escobar-Morreale, R. Barrio, H. de la Calle, M. Alonso, R. Garcia-Robles, and J. Sancho
Identification of the Source of Androgen Excess in Hyperandrogenic Type 1 Diabetic Patients
Diabetes Care, July 1, 2001; 24(7): 1297 - 1299.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Ibáñez, J. DiMartino-Nardi, N. Potau, and P. Saenger
Premature Adrenarche--Normal Variant or Forerunner of Adult Disease?
Endocr. Rev., December 1, 2000; 21(6): 671 - 696.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
H. F. Escobar-Morreale, B. Roldán, R. Barrio, M. Alonso, J. Sancho, H. de la Calle, and R. GarcÍa-Robles
High Prevalence of the Polycystic Ovary Syndrome and Hirsutism in Women with Type 1 Diabetes Mellitus
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4182 - 4187.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Imani, M. J. C. Eijkemans, F. H. de Jong, N. N. Payne, P. Bouchard, L. C. Giudice, and B. C. J. M. Fauser
Free Androgen Index and Leptin Are the Most Prominent Endocrine Predictors of Ovarian Response during Clomiphene Citrate Induction of Ovulation in Normogonadotropic Oligoamenorrheic Infertility
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 676 - 682.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Jaquet, J. Leger, D. Chevenne, P. Czernichow, and C. Levy-Marchal
Intrauterine Growth Retardation Predisposes to Insulin Resistance But Not to Hyperandrogenism in Young Women
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3945 - 3949.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
H. J. H. M. T. van Dessel, P. D. K. Lee, G. Faessen, B. C. J. M. Fauser, and L. C. Giudice
Elevated Serum Levels of Free Insulin-Like Growth Factor I in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3030 - 3035.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-M. Fernández-Real, M. Grasa, R. Casamitjana, M. Pugeat, C. Barret, and W. Ricart
Plasma Total and Glycosylated Corticosteroid-Binding Globulin Levels Are Associated with Insulin Secretion
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3192 - 3196.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. H. Travers, J. I. Labarta, S. E. Gargosky, R. G. Rosenfeld, B. W. Jeffers, and R. H. Eckel
Insulin-Like Growth Factor Binding Protein-I Levels Are Strongly Associated with Insulin Sensitivity and Obesity in Early Pubertal Children
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1935 - 1939.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Ibanez, N. Potau, M. Zampolli, S. RiquE, P. Saenger, and A. Carrascosa
Hyperinsulinemia and Decreased Insulin-Like Growth Factor-Binding Protein-1 Are Common Features in Prepubertal and Pubertal Girls with a History of Premature Pubarche
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2283 - 2288.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Mirza, S. Ezzat, and A. A. Axelrad
Insulin-Like Growth Factor Binding Protein-1 Is Elevated in Patients With Polycythemia Vera and Stimulates Erythroid Burst Formation In Vitro
Blood, March 15, 1997; 89(6): 1862 - 1869.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Simon, M.-A. Charles, K. Nahoul, G. Orssaud, J. Kremski, V. Hully, E. Joubert, L. Papoz, and E. Eschwege
Association between Plasma Total Testosterone and Cardiovascular Risk Factors in Healthy Adult Men: The Telecom Study
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 682 - 685.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society